[HTML][HTML] Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
MG Della Porta, HT Eich, R Foà, MG da Silva… - ESMO open, 2022 - Elsevier
Background The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán… - ESMO …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus
C Buske, M Dreyling, A Alvarez-Larrán… - ESMO …, 2022 - irinsubria.uninsubria.it
Background: The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán… - ESMO …, 2022 - publicum.umed.lodz.pl
Background: The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larran, J Apperley… - ESMO OPEN, 2022 - flore.unifi.it
Background: The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
[引用][C] Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larran, J Apperley… - 2022 - oparu.uni-ulm.de
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larran… - ESMO …, 2022 - epub.ub.uni-muenchen.de
Background: The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán, J Apperley… - ESMO Open, 2022 - hal.science
Background: The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA interdisciplinary expert consensus
C Buske, M Dreyling, A Alvarez-Larrán, J Apperley… - ESMO OPEN, 2022 - air.unimi.it
Background: The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.
C Buske, M Dreyling, A Alvarez-Larrán, J Apperley… - ESMO Open, 2022 - europepmc.org
Background The COVID-19 pandemic has created enormous challenges for the clinical
management of patients with hematological malignancies (HMs), raising questions about …
management of patients with hematological malignancies (HMs), raising questions about …